 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Marksans Pharma Standalone September 2023 Net Sales at Rs 204.67 crore, up 20.21% Y-o-Y

Viraj Vyas advises creating a non-directional spread in Nifty50 by selling 1 lot of 19,100PE and 1 lot of 19,500CE.

Your Nifty strategy for Diwali Muhurat trading, take positions in 10 stocks for Samvat 2080

Gguaifenesin helps loosen phlegm and thin bronchial secretions to rid the bronchial passageways of mucus, the company has said

Marksans Pharma gains on USFDA nod to flu drug

Marksans Pharma Consolidated June 2023 Net Sales at Rs 500.03 crore, up 15.28% Y-o-Y

Marksans Pharma's new tablets are similar to Advil Dual Action which is manufactured by GlaxoSmithKline Consumer Healthcare, a London-based company.

Marksans Pharma shares rally 9% on FDA nod to pain relief tablet

Marksans Pharma Consolidated March 2023 Net Sales at Rs 485.98 crore, up 16.25% Y-o-Y

Marksans Pharma Standalone March 2023 Net Sales at Rs 153.04 crore, down 13.18% Y-o-Y

In November 2022, HDFC Securities initiated coverage on this pharma stock with a buy rating with a bull case target of Rs 66.60, which it achieved in January

Why HDFC Securities is bullish on this smallcap pharma stock?

Famotidine tablets are bioequivalent to the reference listed drug Pepcid AC tablets, a registered trademark of Johnson &amp; Johnson Consumer Inc, which has sales of over $200 million in the US market.

Marksans Pharma climbs 2% after USFDA approval for Famotidine tablets

Marksans Pharma Consolidated December 2022 Net Sales at Rs 479.83 crore, up 32.32% Y-o-Y

Marksans Pharma Ltd. engages in the research, manufacture, marketing, and sale of pharmaceutical formulations. Its product portfolio includes tablets, hard capsules, soft gelatin capsules, oral liquids, and ointments. It operates through the following geographical segments: US and North America, Europe and UK, Australia and New Zealand, India, and Rest of World. The company was founded by Mark Bosco Saldanha on April 16, 1992 and is headquartered in Mumbai, India.

Watchers	181
52-Wk Low	57.90
52-Wk High	172.00

Market Cap	77.33B
Volume (M)	1.67M
52-Wk High	172.00
52-Wk Low	57.90

MARKSANS.NSE Marksans Pharma Ltd .

About

Feed

News

Fundamentals